Cancer Research Collaboration Inc (EIN 461057568) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

Kristi Maya

Phone

5629816101

Tax Period

2024-01-01 to 2024-12-31

Cancer Research Collaboration Inc, founded in 2012, is a small nonprofit in the Medical Research sector that reported $183K in total revenue in fiscal year 2024. Revenue surged 21% from the prior year, signaling strong growth momentum. The organization ran a surplus of $177K, a strong 97% operating margin.

Mission

To conduct and fund scientific research for cancer and various medical research projects and clinical studies.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $183,281

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $183,281

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $0

Other Expenses $5,978

TOTAL EXPENSES $5,978

Year-over-Year Comparison

	2024	2023	Change
Revenue	$183,281	$151,199	+0.2%
Expenses	$5,978	$302,509	-1.0%
Net Income	$177,303	$-151,310	-2.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Kristi Maya	President	10.00	Officer Director	$0	$0	$0
Andre De Fuesco	Board Member	0.10	Officer	$0	$0	$0
Terrie Herrick	Treasurer	0.10	Officer	$0	$0	$0
Deborah Saly	Secretary	0.10	Officer	$0	$0	$0
Terence Webb	Board Member	0.10	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$183,281	$5,978	$1,195,471	$177,303
2023	$151,199	$302,509	$1,116,558	$-151,310
2022	$213,380	$238,786	$1,171,633	$-25,406
2021	$11,003	$109,403	$1,097,037	$-98,400
2020	$66,695	$36,586	$1,551,579	$30,109
2020	$68,228	$179,690	$1,410,008	$-111,462
2019	$1,740,972	$1,741,166	$1,545,255	$-194
2018	$2,055,057	$1,994,676	$2,777,018	$60,381

Cancer Research Collaboration Inc